Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorder
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Garden State Cancer Center at the Center for Molecular Medicine and Immunology
Garden State Cancer Center at the Center for Molecular Medicine and Immunology